RNA as a drug target

Chemistry and Biology

Volumn 4, Issue 6, 1997, Pages 409-414

  Pearson, Neil D ^a   Prescott, Catherine D ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b RNA Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0031171902     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90192-7     Document Type: Article

References (32)

1. Westhof, E., Masquida, B. & Jaeger, L. (1996). RNA tectonics: towards RNA design. Fold Des. 1, R78-R88.
2. Eckstein, F. & Lilley, D.M.J. (eds) (1996). Catalytic RNA Volume 10: Nucleic Acids and Molecular Biology. Springer-Verlag, Berlin, Germany.
3. Hecht, S.M. (1994). RNA degradation by bleomycin, a naturally occurring bioconjugate. Bioconj. Chem. 5, 513-526.
4. Phe, EF-Tu, and a GTP analog. Science 270, 1464-1472.
5. Fourmy, D., Recht, M.I., Blanchard, S.C. & Puglisi, J.D. (1996). Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274, 1367-1371.
6. Scott, W.G., et al., & Klug, A. (1995). Rapid crystallization of chemically synthesized hammerhead RNAs using a double screening procedure. J. Mol. Biol. 250, 327-332.
7. Scott, W.G., Finch, J.T. & Klug, A. (1995). The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavage. Cell 81, 991-200.
8. Nolte, A., Klussmann, S., Bald, R., Erdmann, V.A. and Furste, J.P. (1996). Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat. Biotechnol. 14, 1116-1119.
9. Toniolo, C., Peggion, C., Crisma, M., Formaggio, F., Shui, X. & Eggleston, D.S. (1994). Structure determination of racemic trichogin A IV using centrosymmetric crystals. Struct. Biol. 1, 908-914.
10. Sigurdsson, S.Th. & Eckstein, F. (1996). Site specific labelling of sugar residues in oligoribonucleotides: reactions of aliphatic isocyanates with 2′ amino groups. Nucleic Acids Res. 24, 3129-3133.
11. Allerson, C.R. & Verdine, G.L. (1995). Synthesis and biochemical evaluation of RNA containing an intrahelical disulfide crosslink. Chem. Biol. 2, 667-675
12. Cate, J.H., et al., & Doudna, J.A. (1996). Crystal structure of a group I ribozyme domain: principles of RNA packing. Science 273, 1678-1685.
13. Cate, J.H., et al., & Doudna, J.A. (1996). RNA structure mediation by adenosine platforms. Science 273, 1696-1699.
14. Purohit, P. & Stern, S. (1994). Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature 370, 659-662.
15. Schroeder, R. (1994). Dissecting RNA function. Nature 370, 597-598.
16. Thom, G. & Prescott, C.D. (1997). The selection and characterization of an RNA recognition motif for spectinomycin. Bioorg. Med. Chem., in press.
17. Yuki, A. & Brimacombe, R. (1975). Nucleotide sequences of Escherichia coli 16-S RNA associated with ribosomal proteins S7, S9, S10, S14 and S19. Eur. J. Biochem. 56, 23-34.
18. Samaha, R.R., O'Brien, T., O'Brien, B. & Noller, H.F. (1994). Independent in vitro assembly of a ribonucleoprotein particle containing the 3′ domain of 16S rRNA. Proc. Natl Acad. Sci. USA 91, 7884-7888.
19. Gold, L. (1995). Conformational properties of oligonucleotides. Nucleic Acids Symp. Ser. 33, 20-22.
20. Tuerk, C. & Gold, L (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
21. Bartel, D.P., Zapp, M.L., Green, M.R. & Szostak, J.W. (1991). HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67, 529-536.
22. Schneider, D., Tuerk, C. & Gold, L. (1992). Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J. Mol. Biol. 228, 862-869.
23. Tuerk, C., MacDougal, S. & Gold, L (1992). RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl Acad. Sci. USA 89, 6988-6992.
24. Jellinek, D., Lynott, C.K., Rifkin, D.B. & Janjic, N. (1993). High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl Acad. Sci. USA 90, 11227-11231.
25. Nieuwlandt, D., Wecker, M. & Gold, L. (1995). In vitro selection of RNA ligands to substance P. Biochemistry 34, 5651-5659.
26. Binkley, J., Allen, P., Brown, D.M., Green, L., Tuerk, C. & Gold, L. (1995). RNA ligands to human nerve growth factor. Nucleic Acids Res. 23, 3198-3205.
27. Wallis, M.G., Von Ahsen, U., Schroeder, R. & Famulok, M. (1995). A novel RNA motif for neomycin recognition. Chem. Biol. 2, 543-552.
28. Heaphy, S., Dingwall, C., Ernberg, I., Gait, M. & Skinner, M.A. (1990). HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60, 685-693.
29. Heaphy, S., Finch, J.T., Gait, M., Karn, J. & Singh, M. (1991). Human immunodeficiency virus type 1 regulator of virion expression, Rev, forms nucleoprotein filaments after binding to a purine-rich 'bubble' located within the Rev-responsive region of viral mRNAs. Proc. Natl Acad. Sci. USA 88, 7366-7370.
30. Jain, C. & Belasco, J.G. (1996). A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity Rev variants isolated by a rapid genetic strategy. Cell 87, 115-125.
31. Franklin, N.C. (1993). Clustered arginine residues of bacteriophage lambda N protein are essential to antitermination of transcription, but their locale cannot compensate for boxB loop defects. J. Mol. Biol. 231, 343-360.
32. Harada, K., Martin, S.S. & Frankel, A.D. (1996). Selection of RNA-binding peptides in vivo. Nature 380, 175-179.